The invention generally relates to medical devices and procedures pertaining to prosthetic heart valves. More specifically, the invention relates to replacement of heart valves that may have malformations and/or dysfunctions. Embodiments of the invention relate to a prosthetic heart valve for replacing a mitral valve in the heart, an anchor to facilitate and maintain a positioning of the prosthetic heart valve in the native valve, and deployment devices and procedures associated with implantation of the prosthetic heart valve.
Referring first generally to
When the left ventricle contracts, the blood pressure in the left ventricle increases substantially, and urges the mitral valve closed. Due to the large pressure differential between the left ventricle and the left atrium during ventricular contraction, a possibility of prolapse, or eversion of the leaflets of the mitral valve back into the atrium, arises. To prevent this, a series of chordae tendineae connect the mitral valve to the papillary muscles along opposing walls of the left ventricle. The chordae tendineae are schematically illustrated in both the heart cross-section of
A general shape of the mitral valve and its leaflets as seen from the left atrium is illustrated in
To this point, mitral valve repair has been more popular than valve replacement, where prior research and development has been limited. There are little or no effective commercially available ways to replace a mitral valve through catheter implantation and/or other minimal or less invasive procedures. In contrast, the field of transcatheter aortic valve replacement has developed and has gained widespread success. This discrepancy stems from replacement of a mitral valve being more difficult than aortic valve replacement in many respects, for example, due to the physical structure of the valve and more difficult access to the valve.
The most prominent obstacle for mitral valve replacement is anchoring or retaining the valve in position, due to the valve being subject to a large cyclic load. Especially during ventricular contraction, the movement of the heart and the load on the valve may combine to shift or dislodge a prosthetic valve. Also, the movement and rhythmic load can fatigue materials, leading to fractures of the implanted valve. If the orientation of a mitral prosthesis is unintentionally shifted, blood flow between the left atrium and the left ventricle may be obstructed or otherwise negatively affected. While puncturing the tissue in or around the mitral valve annulus to better anchor an implanted valve is an option for retaining the placement of the implant, this may potentially lead to unintended perforation of the heart and patient injury.
Referring back to
Since many valves have been developed for the aortic position, it would be desirable to try to take advantage of these existing valve technologies and to utilize the same or similar valves in mitral valve replacements. It would therefore be useful to create a mitral anchor or docking station for such preexisting prosthetic valves. An existing valve developed for the aortic position, perhaps with some modification, could then be implanted in such an anchor or docking station. Some previously developed valves may fit well with little or no modification, such as the Edwards Lifesciences Sapien™ valve.
It would therefore be desirable to provide devices and methods that can be utilized in a variety of implantation approaches to facilitate the docking or anchoring of such valves. Embodiments of the invention provide a stable docking station for retaining a mitral valve replacement prosthesis. Other devices and methods are provided to improve the positioning and deployment of such docking stations and/or the replacement prosthesis therein, for example, during various non-invasive or minimally invasive procedures. The devices and methods may also serve to prevent or greatly reduce regurgitation or leaking of blood around the replacement prosthesis, such as leakage through the commissures of the native mitral valve outside of the prosthesis.
Features of the invention are directed to a docking or anchoring device that more effectively anchors a replacement valve prosthesis in the mitral valve annulus. Other features of the invention are directed to a replacement valve prosthesis that more effectively interacts with an anchoring device according to embodiments of the invention and with surrounding portions of the native mitral valve and other portions of the heart. Still other features of the invention are directed to docking or anchoring devices and methods for more effectively deploying different portions of the anchoring devices above and below the native mitral valve annulus (i.e., deploying separate portions of the anchoring devices into the left atrium and left ventricle, respectively). Still other features of the invention are directed to corralling or holding the chordae tendineae together during deployment of the docking or anchoring devices, to more easily position the docking or anchoring devices around the native valve leaflets and the chordae tendineae.
In an embodiment of the invention, a coiled anchor for docking a mitral valve prosthesis at a native mitral valve of a heart has a first end, a second end, and a central axis extending between the first and second ends, and defines an inner space coaxial with the central axis. The coiled anchor includes a coiled core including a bio-compatible metal or metal alloy and having a plurality of turns extending around the central axis in a first position, and a cover layer around the core, the cover layer including a bio-compatible material that is less rigid than the metal or metal alloy of the coiled core. The coiled anchor is adjustable from the first position to a second position wherein at least one of the plurality of turns is straightened for the coiled anchor to be delivered through a catheter to the native mitral valve, and from the second position back to the first position. The coiled anchor is implantable at the native mitral valve with at least a portion on one side of the native mitral valve in a left atrium of the heart and at least a portion on an opposite side of the native mitral valve in a left ventricle of the heart, to support or hold the mitral valve prosthesis in the inner space when the coiled anchor is implanted at the native mitral valve
In another embodiment, the coiled anchor can be included in a system for implanting at a mitral valve, where the system can further include a mitral valve prosthesis including an expandable frame and housing a plurality of leaflets for controlling blood flow therethrough, wherein the frame is expandable from a collapsed first position wherein the frame has a first outer diameter for delivery of the mitral valve prosthesis through a catheter to an expanded second position wherein the frame has a second outer diameter greater than the first outer diameter. When the coiled anchor and the mitral valve prosthesis are unbiased, a smallest inner diameter of the inner space defined by the coil anchor can be smaller than the second outer diameter of the mitral valve prosthesis.
In another embodiment, a coiled anchor for docking a mitral valve prosthesis at a native mitral valve of a heart has a first end, a second end, and a central axis extending between the first and second ends, and defines an inner space coaxial with the central axis. The coiled anchor includes a first coil having a plurality of turns in a first circumferential direction and extending from a first end to a second end, a second coil having a plurality of turns in a second circumferential direction opposite to the first circumferential direction and extending from a first end to a second end, and a joint configured to hold the first end of the first coil and the first end of the second coil together, such that the first and second coils each extends away from the joint and from one another along the central axis. The coiled anchor has a first position where the respective turns of the first coil and the second coil each extends around the central axis. The coiled anchor is adjustable from the first position to a second position wherein at least one of the plurality of turns of the first coil or the second coil is straightened for the coiled anchor to be delivered through a catheter to the native mitral valve, and from the second position back to the first position. The coiled anchor is implantable at the native mitral valve with at least a portion of the first coil on one side of the native mitral valve in a left atrium of the heart, and at least a portion of the second coil on an opposite side of the native mitral valve in a left ventricle of the heart, to support or hold the mitral valve prosthesis in the inner space when the coiled anchor is implanted at the native mitral valve.
In another embodiment, a method for delivering a coiled anchor that is configured to dock a mitral valve prosthesis at a native mitral valve of a heart includes positioning a catheter for delivery of the coiled anchor at the native mitral valve, positioning a loop around chordae tendineae, closing the loop to draw the chordae tendineae together, advancing the coiled anchor out of the catheter and around the chordae tendineae, and removing the loop and the catheter.
According to embodiments of the invention, mitral valve replacement can be realized through a variety of different implantation approaches. Embodiments of the invention thus provide flexibility with different ways and options for implanting a replacement mitral valve.
Further features and advantages of the invention will become apparent from the description of embodiments using the accompanying drawings. In the drawings:
A helical anchor according to an embodiment of the invention is constructed as seen in
As can be seen most clearly in
In one embodiment, a core 180 of the helical coil 72 is constructed of or includes a shape memory material, such as Nitinol. However, in other embodiments, the core 180 of the helical coil 72 can be made of or include other bio-compatible materials, for example, other alloys, or for example, metals such as titanium or stainless steel. In some embodiments, the coil can have enlarged and/or rounded ends, for example, to prevent tips at ends of the coil 72 from damaging surrounding tissue during deployment. As can best be seen in
In greater detail, in some embodiments, the fabric or cloth cover 184 that covers the helical coil is, for example, a polyethylene terephthalate (PET) polyester material. The fabric can have a thickness of 0.008±0.002 inches, and can have density characteristics of, for example, 2.12±0.18 oz/yd2, 40±5 wales/inch, and 90±10 courses/inch. The fabric layer can further be cut to have a length or width of approximately 13+1/−0.5 inches in order to cover substantially an entire length of the helical coil 72.
In some embodiments, the foam layer 182 can be cut to 19 mm×5 mm, and the cloth cover 184 can be cut to 19 mm×6 mm. However, other sized cuts of the various layers 182, 184 can also be utilized, depending on for example, the size of the helical coil, the thickness of the respective layers, and the amount of each layer intended for covering the core 180. In some embodiments, the foam layer 182 can be attached to the cloth cover 184 using, for example, 22 mm of polytetrafluoroethylene (PTFE) suture with a light straight stitch. The foam layer 182 and/or the cloth cover 184 can be folded around the coil core 180 and cross-stitched to the core 180 using, for example, 45 mm of fiber suture. However, the invention should not be limited to these attachment properties, and other suture sizes and/or types, or any of various other attachment means or methods for effectively attaching the foam layer 182 and/or the cloth cover 184 to the coil core 180, can also be utilized and implemented. For example, in some embodiments, the core can be a modified core with through holes, notches, or other features that can be laser cut or otherwise formed along the core. Such features in the core can be used to interact with sutures, to increase friction, or to otherwise help hold a cover layer or layers against the core and prevent or restrict sliding or other relative movement between the cover layer and the core. In some embodiments, the core can also be formed to have a non-circular cross-section to increase a contact area between the core and the cover layer. For example, a flat wire coil can be used to form the core. Additionally, various bio-compatible adhesives or other materials can be applied between the core and the cover layer in order to more securely hold a position of the cover layer relative to the core. In some embodiments, a hydrogel or other material that expands upon contact with blood can be applied between the core and the cover layer as a gap filler to create a stronger seal or interference fit between the core and the cover layer.
According to embodiments of the invention, mitral valve replacement can be performed in various different manners. In one procedure using catheters, an anchoring or docking station as described above and/or a prosthetic valve to be positioned in the anchor (which may initially be compressed or collapsed radially) can be delivered through blood vessels to the implant site. This can be accomplished, for example, through arteries or veins connected to various chambers of the heart. In one exemplary embodiment (as will be seen in
In some cases, mitral valve replacement may not be purely performed percutaneously through remote arteries and/or veins, and a more open procedure may be necessary. In these cases, for example, practitioners can make a small chest incision (thoractomy) to gain access to the heart, and then place catheter-based delivery devices and/or the implants directly into the heart.
Referring now to the embodiment in
As shown in
In other embodiments, the coil guide catheter 68 can be introduced into the heart as a relatively straight element, and can then be manipulated to take on the desired curved shape.
As shown in
The helical anchor 72 is then further advanced by being pushed through the coil guide catheter 68.
After the lower coils 82 of the anchor 72 have been placed under the mitral valve annulus, as seen in
After the helical anchor 72 is fully implanted, the coil guide catheter 68 is removed, as can be seen in
It should also be noted that once a helical anchor 72 is inserted and positioned as described above, and prior to implantation of a prosthetic valve therein, the native mitral valve 44 can continue to operate substantially normally, and the patient can remain stable. Therefore, the procedure can be performed on a beating heart without the need for a heart-lung machine. Furthermore, this allows a practitioner more time flexibility to implant a valve prosthesis within the anchor 72, without the risk of the patient being in a position of hemodynamic compromise if too much time passes between anchor implantation and valve implantation.
As shown in
After the lower coils of the anchor 330 have been positioned under the mitral valve 44 to a desired orientation, the upper coils of the anchor 330 can then be deployed from the coil guide catheter 340, for example, by rotating the coil guide catheter 340 in the opposite direction of advancement of the anchor 330, as shown in
In
In embodiments of the invention, a collapsed valve prosthesis 120 is first positioned in a central passage or inner space defined by the anchor 72, and is then expanded to abut against and dock in the anchor 72. In these embodiments, at least a portion of the leaflet tissue 38, 42 of the mitral valve 44 is secured or pinned between the anchor 72 and the valve prosthesis 120 to lock the anchor 72 and valve prosthesis 120 in position and prevent them from shifting or dislodging. The tissue of leaflets 38, 42 also creates a natural seal to prevent blood flow between the valve prosthesis 120 and the helical anchor 72. As discussed above, in some embodiments, a smallest inner diameter defined by the coils of the anchor 72 is smaller than a diameter of the valve prosthesis 120 after it has been expanded, such that a radial resistance force is formed between the anchor 72 and the valve prosthesis 120, which further secures the parts together. Pressure between the anchor 72 and the valve prosthesis 120 can occur either above or below the mitral valve 44, or both. Due to the pressure formed between the anchor 72, the valve prosthesis 120, and the leaflets 38, 42 therebetween, generally no additional sutures or attachments between the valve prosthesis 120 and the anchor 72 or the adjacent heart tissue is needed. Due to the different materials used for the anchor 72 and the prosthesis 120, a circumferential friction force is also generated between parts of the anchor 72 and the prosthesis 120 that contact one another, thereby restricting uncoiling and expansion of the anchor 72. This interaction will be discussed in greater detail below, with reference to
Attached or integral along a distal or lower end of the frame 220, the valve prosthesis further includes an annular ring or cuff 224 which is made of or generally includes materials that are less rigid than the materials of the frame 220.
In addition, the foam layer and/or fabric layer further serve to create additional friction upon contact between the anchor 72 and the frame of valve prosthesis 120 anchored therein. In the case of metal-based anchoring or docking stations that do not further include a foam and/or fabric layer thereupon, the material or materials of the anchoring or docking station may be similar to or the same as the material or materials making up the stent frame of the valve prosthesis. In these instances, when the valve prosthesis is expanded in the coil anchor and the stent frame of the prosthesis begins to contact the coil anchor, there may be minimal or low frictional resistance between the stent frame and the coil anchor. Since the unbiased inner diameter of the coil anchor is generally smaller than the outer diameter of the expanded valve prosthesis, and due to the general wound structure of the helical coil, expansion of the valve prosthesis against the helical coil will urge at least the smallest diameter turns of the coil anchor to stretch radially outward and to partially unwind. This, in turn, can cause a slight dislodging or shifting of the anchor within the mitral valve annulus that may be undesirable and cause less effective functionality of the implanted valve prosthesis, or in a worst case, may lead to a weaker anchoring of the valve prosthesis in the coil anchor and potential embolization of the valve prosthesis out of the mitral valve annulus and into the left atrium or the left ventricle.
The foam and/or cloth or fabric covered coil anchor 72 according to embodiments of the invention serve to add friction between the coil anchor 72 and valve prosthesis 120 upon contact between the respective parts. Initially, when the valve prosthesis 120 is expanded in the coil anchor 72 during implantation of the replacement valve, the metal or metal alloy frame 220 of the valve 120 will come into contact with the foam 182 or fabric 184 layer of the coil anchor 72, and a circumferential frictional force between the contacting surfaces prevents the coil anchor 72 from sliding or unwinding under the radially outward forces applied by the expanding frame 220. Such frictional forces can be generated, for example, from the difference in materials between the outer surface of the cloth or foam covered coil 72 and the metal or alloy frame 220 of the valve prosthesis 120, from interference between the texturing of the cloth or foam covered coil 72 against the metal or alloy surface or various edges of the expandable stent frame 220 of the prosthesis 120, or from an interference or “catching” between the cloth or foam covered coil 72 with the edges, transitions or hinges, and/or stitchings on the outer surface of the frame 220 of the prosthesis 120. In other embodiments, other means or reasons for a circumferential friction or locking between the surfaces of the coil anchor 72 and the valve prosthesis 120 can be utilized or employed, in order to prevent or reduce circumferential migration or expansion of the helical coil 72 upon radially outward pressure applied from the expanding valve prosthesis 120.
According to embodiments of the invention, a helical coil 72 with a predefined opening size can more accurately be selected and implanted in a mitral valve annulus for holding or supporting a valve prosthesis therein. A surgeon or practitioner can more accurately select a coil size and shape together with a desired valve type and size, and the interaction between the pieces after implantation will be more predictable and robust. The valve prosthesis can be retained more securely in the coil anchor 72, since there will be a tighter hold or retention force between the anchor and the prosthesis, and since there will be less expansion, shifting, or migration of the anchor within the native mitral valve annulus upon expansion of the prosthesis therein.
Furthermore, the characteristics of the cloth or foam covered coil anchor 72 according to embodiments of the invention can also assist in easier implantation and positioning of the coil anchor 72 itself in the mitral valve annulus, prior to delivery of the valve prosthesis. First, due to the additional frictional forces contributing to helping later maintain the structural integrity and/or general size and shape of the coil anchor 72 against an expanded valve prosthesis, the core of the coil can be made to be thinner and/or more flexible, which makes the initial delivery of the coil anchor 72 through the coil guide catheter and into position in the mitral valve annulus easier. In addition, while a coil with a smaller diameter inner opening generally holds a valve prosthesis more securely, since undesired expansion of the coil anchor 72 by the valve prosthesis is prevented or reduced, the coil anchor 72 can also be made slightly larger than comparable coil anchors without a foam/cloth cover layer, and advancement of the anchor 72 around the native mitral valve leaflets and chordae tendineae during deployment of the anchor 72 can be more easily facilitated.
Referring now to
The flaring exhibited in the valve prosthesis 120 provides a number of benefits. The locking dynamic created between the contacting surfaces of the coil anchor and the valve prosthesis, coupled with the flared frame geometry of the prosthesis 120, combine to increase retention of the anchor within the coil anchor and the mitral valve annulus. The flaring and widening of the ends of the valve prosthesis 120 add a dimension to the ends of the prosthesis that serve to create an additional abutment and obstacle against dislodging of the valve from the coil anchor and potential embolization of the valve under elevated pressures within the heart. In preliminary tests, while pulsatile pressures up to 70 mmHG and static pressures up to 150 mmHg applied against a valve prosthesis anchored in an uncovered metal coil in separate tests did not dislodge the prosthetic valve from the coil anchor, the prosthetic valve did dislodge from the uncovered anchor at higher static pressures, for example, pressures above 290 mmHg. Meanwhile, prosthetic valves that were anchored in a covered coil anchor according to embodiments of the invention were successfully retained in all of the above tests. Therefore, a prosthetic valve can be more effectively retained in a foam and/or cloth covered coil anchor. In addition, flaring of the sub-annular portion of the prosthetic valve (i.e., the portion of the valve located in the left ventricle) will also more securely pinch or hold the native leaflets of the mitral valve against sub-annular portions of the coil anchor, further improving retention of the implant.
Flaring of the ends of the valve prosthesis 120 will increase contact between the prosthesis 120 and the surrounding heart tissue, such as the native mitral valve leaflets and the chordae tendineae. This could potentially lead to damage of the surrounding tissue by sharp edges or corners on the frame 220 of the valve. Referring back to the valve prosthesis illustrated in
As seen in the previously described embodiments, the annular cuff 224 is realized as a continuous annular ring covering at least the corners on one end of the stent frame 220 of the valve prosthesis. Meanwhile,
The coil anchor 72 described in the previous embodiments is made up of or includes one helical coil.
The coil anchor 400 can initially be deployed similarly to the coil anchor 72 in previously described embodiments. As seen in
The coil anchor 400 is advanced until the joint 406 exits the distal end of the coil guide catheter 68. Additional adjustments of the anchor to a final desired position may further be made by the practitioner after the coil anchor 400 has exited the catheter 68, as needed. As can be seen in
In some embodiments, the upper and lower coils 402, 404 of the coil anchor 400 can be staggered, where the lower coil 404 is slightly longer than the upper coil 402. In this manner, the distal end 410 of the lower coil 404 is configured to exit the distal end of the coil guide catheter 68 first, for easier positioning of the distal end 410 through the valve at the commissure 80. After the distal end 410 of the lower coil 404 is positioned through the valve at the commissure 80, the anchor 400 can be fully advanced and positioned without adjustment, or with only minor adjustments, to the position of the coil guide catheter 68. In other embodiments, the upper and lower coils 402, 404 are substantially the same length, or the upper coil 402 can be longer than the lower coil 404. The relative lengths of the two coils of the coil anchor 400 can be adjusted based on the needs of the patient and the preferences of the practitioner, among other factors.
As has been seen in previous embodiments, different coil anchors can be deployed at the mitral position in different manners. In each embodiment, it is important that the leading end, or distal end, of the sub-annular coil (i.e., the portion of the coil anchor that advances through the mitral valve into the left ventricle) is directed completely around the native leaflets of the mitral valve and around the chordae tendineae, in order for the anchor to remain closely positioned to the mitral valve annulus. For example, if the distal end of the coil does not go completely around the chordae tendineae, and is instead advanced between two chordae, the coil may become entangled in the chordae, and/or the sub-annular portion of the coil anchor may be held under tissue where the two chordae meet, and thus be deflected farther away from the valve annulus than desired. Such a scenario can have negative effects, such as damage to the coil anchor and/or the chordae tendineae or the native mitral valve leaflets, or unstable anchoring or poor positioning of a valve prosthesis that is held in the coil anchor.
In addition to the catheters associated with the delivery of the helical anchor, a separate catheter 18 can be included in the deployment system, and can also be fed and advanced through the introducer 2 or other sheath or cannula in the deployment system. At a distal end of the catheter 18, a temporary ring or loop 22 is provided, which is used to corral, bundle, “lasso,” or otherwise draw the chordae tendineae 48 together prior to deployment of the helical anchor 72. The chordae tendineae 48 then occupy a smaller cross-sectional area in the left ventricle 10, which facilitates easier later deployment of the distal tip of the helical anchor 72 around the chordae, and placement of the helical anchor 72 in the desired or optimal position without any chordal entanglement.
The temporary ring or loop 22 can be, for example, a suture or a guide wire, or any other suitable thread or wire. In some embodiments, the loop 22 is led or guided around the chordae tendineae 48 with for example, a grasping tool or one or more other tools introduced through the introducer 2 or through another delivery sheath or cannula. In other embodiments, the loop 22 is advanced through one or more segmented guiding catheters around the chordae tendineae 48. In these embodiments, the loop 22 is closed, for example, by utilizing a clamping tool or a grasping tool, via tying, or by one of various other attachment methods, and then the segments of the guiding catheter or catheters are retracted, leaving the loop 22 in its final position around the chordae. In yet other embodiments, the loop 22, like the helical anchor 72, is pre-formed to have a curvature, such that the loop 22 surrounds the chordae tendineae as it is deployed. In some embodiments, after the loop 22 has been closed, an opening defined by the loop 22 can further be tightened or narrowed, to further bundle or corral the chordae tendineae 48 closer together. Meanwhile, while
After the loop 22 is deployed around the chordae tendineae 48 and bundles or otherwise draws the chordae together, and after the helical coil anchor 72 is deployed fully around the chordae and is satisfactorily docked in the mitral position, the loop 22 is removed. This can be accomplished, for example, by a release of the grasping tool if one is utilized, and/or by untying or cutting the suture, thread, or guide wire used for the loop 22, and then removing the loop together with the other tools and catheters in the deployment system from the access site.
In embodiments where a loop as described above is utilized in a coil anchor deployment system, issues arising from a coil anchor being entangled in the chordae tendineae during deployment, or from a coil anchor being stuck between two or more chordae and being positioned incorrectly, can be mitigated or prevented. In this manner, the anchor can be more securely positioned, and a valve prosthesis can also be more securely deployed and implanted therein.
Various other modifications or alternative configurations can be made to the helical anchors, valve prostheses, and/or deployment systems according to the above described embodiments of the invention. For example, in the illustrated embodiments, the coils of the helical anchors are tightly wound near the mitral valve annulus. In other embodiments, some of the coils of the anchor may be widened or flared outwards to make contact with, for example, the atrial wall of the left atrium. Furthermore, the number of coils both above and below the valve annulus can be varied, based on for example, properties of the native mitral valve and/or desired positioning of the valve prosthesis. In embodiments where upper and lower coils are joined together to form the helical anchor, the two coils can be prepared, modified, and/or selected separately based on a patient's anatomy or various other factors. In addition, other modifications to the deployment system can be employed in order to more efficiently or effectively bundle the chordae tendineae during deployment and positioning of the helical anchor. Various other coil shapes, lengths, and arrangements and modifications can also be made based on a wide range of considerations.
For purposes of this description, certain aspects, advantages, and novel features of the embodiments of this disclosure are described herein. The disclosed methods, apparatus, and systems should not be construed as being limiting in any way. Instead, the present disclosure is directed toward all novel and nonobvious features and aspects of the various disclosed embodiments, alone and in various combinations and sub-combinations with one another. The methods, apparatus, and systems are not limited to any specific aspect or feature or combination thereof, nor do the disclosed embodiments require that any one or more specific advantages be present or problems be solved.
Although the operations of some of the disclosed embodiments are described in a particular, sequential order for convenient presentation, it should be understood that this manner of description encompasses rearrangement, unless a particular ordering is required by specific language set forth below. For example, operations described sequentially may in some cases be rearranged or performed concurrently. Moreover, for the sake of simplicity, the attached figures may not show the various ways in which the disclosed methods can be used in conjunction with other methods. Additionally, the description sometimes uses terms like “provide” or “achieve” to describe the disclosed methods. These terms are high-level abstractions of the actual operations that are performed. The actual operations that correspond to these terms may vary depending on the particular implementation and are readily discernible by one of ordinary skill in the art.
In view of the many possible embodiments to which the principles of the disclosure may be applied, it should be recognized that the illustrated embodiments are only preferred examples and should not be taken as limiting the scope of the disclosure. Rather, the scope of the disclosure is defined by the following claims.
The present application is a continuation of U.S. patent application Ser. No. 15/912,971, filed on Mar. 6, 2018, which is a division of U.S. patent application Ser. No. 14/628,020, filed Feb. 20, 2015, which is a continuation-in-part of International Application PCT/US2014/051095 filed Aug. 14, 2014, which claims the benefit of U.S. Provisional Patent Application Nos. 61/865,657 filed Aug. 14, 2013, 61/942,300 filed Feb. 20, 2014, and 61/943,125 filed Feb. 21, 2014, all of which are hereby incorporated by reference in their entirety.
Number | Name | Date | Kind |
---|---|---|---|
3564617 | Sauvage et al. | Feb 1971 | A |
3755823 | Hancock | Sep 1973 | A |
4035849 | Angell et al. | Jul 1977 | A |
4490859 | Black et al. | Jan 1985 | A |
4512338 | Balko et al. | Apr 1985 | A |
4759758 | Gabbay | Jul 1988 | A |
4777951 | Cribier et al. | Oct 1988 | A |
4787899 | Lazarus | Nov 1988 | A |
4790843 | Carpentier et al. | Dec 1988 | A |
4796629 | Grayzel | Jan 1989 | A |
4856516 | Hillstead | Aug 1989 | A |
4878495 | Grayzel | Nov 1989 | A |
4966604 | Reiss | Oct 1990 | A |
4994077 | Dobben | Feb 1991 | A |
5059177 | Towne et al. | Oct 1991 | A |
5192297 | Hull | Mar 1993 | A |
5282847 | Trescony et al. | Feb 1994 | A |
5370685 | Stevens | Dec 1994 | A |
5403305 | Sauter et al. | Apr 1995 | A |
5411552 | Andersen et al. | May 1995 | A |
5443500 | Sigwart | Aug 1995 | A |
5545214 | Stevens | Aug 1996 | A |
5554185 | Block et al. | Sep 1996 | A |
5558644 | Boyd et al. | Sep 1996 | A |
5584803 | Stevens et al. | Dec 1996 | A |
5591195 | Taheri et al. | Jan 1997 | A |
5607464 | Trescony et al. | Mar 1997 | A |
5665115 | Cragg | Sep 1997 | A |
5769812 | Stevens et al. | Jun 1998 | A |
5800508 | Goicoechea et al. | Sep 1998 | A |
5840081 | Andersen et al. | Nov 1998 | A |
5855597 | Jayaraman | Jan 1999 | A |
5855601 | Bessler et al. | Jan 1999 | A |
5925063 | Khosravi | Jul 1999 | A |
5957949 | Leonhardt et al. | Sep 1999 | A |
6027525 | Suh et al. | Feb 2000 | A |
6120534 | Ruiz | Sep 2000 | A |
6168614 | Andersen et al. | Jan 2001 | B1 |
6221091 | Khosravi | Apr 2001 | B1 |
6235042 | Katzman | May 2001 | B1 |
6245102 | Jayaraman | Jun 2001 | B1 |
6302906 | Goicoechea et al. | Oct 2001 | B1 |
6306141 | Jervis | Oct 2001 | B1 |
6406492 | Lytle | Jun 2002 | B1 |
6409758 | Stobie et al. | Jun 2002 | B2 |
6419696 | Ortiz et al. | Jul 2002 | B1 |
6425916 | Garrison et al. | Jul 2002 | B1 |
6432134 | Anson et al. | Aug 2002 | B1 |
6454799 | Schreck | Sep 2002 | B1 |
6458153 | Bailey et al. | Oct 2002 | B1 |
6461382 | Cao | Oct 2002 | B1 |
6482228 | Norred | Nov 2002 | B1 |
6527979 | Constantz | Mar 2003 | B2 |
6582462 | Andersen et al. | Jun 2003 | B1 |
6625578 | Spaur et al. | Sep 2003 | B2 |
6652578 | Bailey et al. | Nov 2003 | B2 |
6730118 | Spenser et al. | May 2004 | B2 |
6730121 | Ortiz et al. | May 2004 | B2 |
6733525 | Yang et al. | May 2004 | B2 |
6767362 | Schreck | Jul 2004 | B2 |
6797002 | Spence et al. | Sep 2004 | B2 |
6830584 | Seguin | Dec 2004 | B1 |
6878162 | Bales et al. | Apr 2005 | B2 |
6893460 | Spenser et al. | May 2005 | B2 |
6908481 | Cribier | Jun 2005 | B2 |
6971998 | Rosenman et al. | Dec 2005 | B2 |
7018406 | Seguin et al. | Mar 2006 | B2 |
7018408 | Bailey et al. | Mar 2006 | B2 |
7037334 | Hlavka et al. | May 2006 | B1 |
7077861 | Spence | Jul 2006 | B2 |
7101395 | Tremulis et al. | Sep 2006 | B2 |
7125421 | Tremulis et al. | Oct 2006 | B2 |
7166126 | Spence et al. | Jan 2007 | B2 |
7166127 | Spence et al. | Jan 2007 | B2 |
7276078 | Spenser et al. | Oct 2007 | B2 |
7276084 | Yang et al. | Oct 2007 | B2 |
7318278 | Zhang et al. | Jan 2008 | B2 |
7374571 | Pease et al. | May 2008 | B2 |
7393360 | Spenser et al. | Jul 2008 | B2 |
7404824 | Webler et al. | Jul 2008 | B1 |
7431726 | Spence et al. | Oct 2008 | B2 |
7445632 | McGuckin, Jr. et al. | Nov 2008 | B2 |
7462191 | Spenser et al. | Dec 2008 | B2 |
7510575 | Spenser et al. | Mar 2009 | B2 |
7527646 | Rahdert et al. | May 2009 | B2 |
7585321 | Cribier | Sep 2009 | B2 |
7618446 | Andersen et al. | Nov 2009 | B2 |
7618449 | Tremulis et al. | Nov 2009 | B2 |
7637946 | Solem et al. | Dec 2009 | B2 |
7655034 | Mitchell et al. | Feb 2010 | B2 |
7708775 | Rowe et al. | May 2010 | B2 |
7737060 | Strickler et al. | Jun 2010 | B2 |
7758639 | Mathis | Jul 2010 | B2 |
7780726 | Seguin | Aug 2010 | B2 |
7785366 | Maurer et al. | Aug 2010 | B2 |
7942927 | Kaye et al. | May 2011 | B2 |
7951195 | Antonsson et al. | May 2011 | B2 |
7955385 | Crittenden | Jun 2011 | B2 |
7959672 | Salahieh et al. | Jun 2011 | B2 |
7967857 | Lane | Jun 2011 | B2 |
7993394 | Hariton et al. | Aug 2011 | B2 |
8016882 | Macoviak et al. | Sep 2011 | B2 |
8029556 | Rowe | Oct 2011 | B2 |
8052750 | Tuval et al. | Nov 2011 | B2 |
8092520 | Quadri | Jan 2012 | B2 |
8128691 | Keranen | Mar 2012 | B2 |
8142492 | Forster et al. | Mar 2012 | B2 |
8167932 | Bourang et al. | May 2012 | B2 |
8167935 | McGuckin, Jr. | May 2012 | B2 |
8236049 | Rowe et al. | Aug 2012 | B2 |
8323335 | Rowe et al. | Dec 2012 | B2 |
8377115 | Thompson | Feb 2013 | B2 |
8398708 | Meiri et al. | Mar 2013 | B2 |
8449605 | Lichtenstein et al. | May 2013 | B2 |
8449606 | Eliasen et al. | May 2013 | B2 |
8652203 | Quadri et al. | Feb 2014 | B2 |
8657872 | Seguin | Feb 2014 | B2 |
8663322 | Keranen | Mar 2014 | B2 |
8672998 | Lichtenstein et al. | Mar 2014 | B2 |
8685086 | Navia et al. | Apr 2014 | B2 |
8734507 | Keranen | May 2014 | B2 |
8795352 | O'Beime et al. | Aug 2014 | B2 |
8801776 | House et al. | Aug 2014 | B2 |
8986373 | Chau et al. | Mar 2015 | B2 |
9078747 | Conklin | Jul 2015 | B2 |
9095434 | Rowe | Aug 2015 | B2 |
9119718 | Keranen | Sep 2015 | B2 |
9180006 | Keranen | Nov 2015 | B2 |
9192471 | Bolling | Nov 2015 | B2 |
9237886 | Seguin et al. | Jan 2016 | B2 |
9314335 | Konno | Apr 2016 | B2 |
9364326 | Yaron | Jun 2016 | B2 |
9463268 | Spence | Oct 2016 | B2 |
9474599 | Keranen | Oct 2016 | B2 |
9597205 | Tuval | Mar 2017 | B2 |
9622863 | Karapetian et al. | Apr 2017 | B2 |
9700409 | Braido et al. | Jul 2017 | B2 |
20020026094 | Roth | Feb 2002 | A1 |
20020032481 | Gabbay | Mar 2002 | A1 |
20020045936 | Moe | Apr 2002 | A1 |
20020055773 | Campbell et al. | May 2002 | A1 |
20020107535 | Wei et al. | Aug 2002 | A1 |
20020138135 | Duerig et al. | Sep 2002 | A1 |
20020151970 | Garrison et al. | Oct 2002 | A1 |
20020173841 | Ortiz et al. | Nov 2002 | A1 |
20030050694 | Yang et al. | Mar 2003 | A1 |
20030100939 | Yodfat et al. | May 2003 | A1 |
20030158597 | Quiachon et al. | Aug 2003 | A1 |
20030167089 | Lane | Sep 2003 | A1 |
20030212454 | Scott et al. | Nov 2003 | A1 |
20030225420 | Wardle | Dec 2003 | A1 |
20040111006 | Alferness et al. | Jun 2004 | A1 |
20040167620 | Ortiz et al. | Aug 2004 | A1 |
20040186563 | Lobbi | Sep 2004 | A1 |
20040186565 | Schreck | Sep 2004 | A1 |
20040260389 | Case et al. | Dec 2004 | A1 |
20050096736 | Osse et al. | May 2005 | A1 |
20050119682 | Nguyen et al. | Jun 2005 | A1 |
20050119735 | Spence et al. | Jun 2005 | A1 |
20050137691 | Salahieh et al. | Jun 2005 | A1 |
20050149178 | Spence | Jul 2005 | A1 |
20050182486 | Gabbay | Aug 2005 | A1 |
20050203614 | Forster et al. | Sep 2005 | A1 |
20050203617 | Forster et al. | Sep 2005 | A1 |
20050228496 | Mensah et al. | Oct 2005 | A1 |
20050234546 | Nugent et al. | Oct 2005 | A1 |
20060020327 | Lashinski et al. | Jan 2006 | A1 |
20060025857 | Bergheim et al. | Feb 2006 | A1 |
20060052867 | Revuelta et al. | Mar 2006 | A1 |
20060058872 | Salahieh et al. | Mar 2006 | A1 |
20060149350 | Patel et al. | Jul 2006 | A1 |
20060195134 | Crittenden | Aug 2006 | A1 |
20060195185 | Lane et al. | Aug 2006 | A1 |
20060265056 | Nguyen et al. | Nov 2006 | A1 |
20070005131 | Taylor | Jan 2007 | A1 |
20070010876 | Salahieh et al. | Jan 2007 | A1 |
20070010877 | Salahieh et al. | Jan 2007 | A1 |
20070112422 | Dehdashtian | May 2007 | A1 |
20070185572 | Solem et al. | Aug 2007 | A1 |
20070203503 | Salahieh et al. | Aug 2007 | A1 |
20070203575 | Forster et al. | Aug 2007 | A1 |
20070213813 | Von Segesser et al. | Sep 2007 | A1 |
20070232898 | Huynh et al. | Oct 2007 | A1 |
20070244553 | Rafiee et al. | Oct 2007 | A1 |
20070265700 | Eliasen et al. | Nov 2007 | A1 |
20070293808 | Williams et al. | Dec 2007 | A1 |
20080004697 | Lichtenstein et al. | Jan 2008 | A1 |
20080021547 | Davidson | Jan 2008 | A1 |
20080033542 | Antonsson et al. | Feb 2008 | A1 |
20080077235 | Kirson | Mar 2008 | A1 |
20080114442 | Mitchell et al. | May 2008 | A1 |
20080125853 | Bailey et al. | May 2008 | A1 |
20080200977 | Paul et al. | Aug 2008 | A1 |
20080200980 | Robin et al. | Aug 2008 | A1 |
20080208330 | Keranen | Aug 2008 | A1 |
20080228265 | Spence et al. | Sep 2008 | A1 |
20080243245 | Thambar et al. | Oct 2008 | A1 |
20080275503 | Spence et al. | Nov 2008 | A1 |
20090005863 | Goetz et al. | Jan 2009 | A1 |
20090088836 | Bishop et al. | Apr 2009 | A1 |
20090099653 | Suri et al. | Apr 2009 | A1 |
20090157175 | Benichou | Jun 2009 | A1 |
20090177278 | Spence | Jul 2009 | A1 |
20090192601 | Rafiee et al. | Jul 2009 | A1 |
20090234318 | Loulmet et al. | Sep 2009 | A1 |
20090259307 | Gross et al. | Oct 2009 | A1 |
20090276038 | Tremulis et al. | Nov 2009 | A1 |
20090276040 | Rowe et al. | Nov 2009 | A1 |
20090281619 | Le et al. | Nov 2009 | A1 |
20090299471 | Keranen | Dec 2009 | A1 |
20090319037 | Rowe et al. | Dec 2009 | A1 |
20100036484 | Hariton et al. | Feb 2010 | A1 |
20100049313 | Alon et al. | Feb 2010 | A1 |
20100076548 | Konno | Mar 2010 | A1 |
20100076549 | Keidar et al. | Mar 2010 | A1 |
20100145440 | Keranen | Jun 2010 | A1 |
20100152839 | Shandas et al. | Jun 2010 | A1 |
20100161047 | Cabiri | Jun 2010 | A1 |
20100168844 | Toomes et al. | Jul 2010 | A1 |
20100198347 | Zakay et al. | Aug 2010 | A1 |
20100217382 | Chau et al. | Aug 2010 | A1 |
20100217385 | Thompson et al. | Aug 2010 | A1 |
20100312333 | Navia et al. | Dec 2010 | A1 |
20100318183 | Keranen | Dec 2010 | A1 |
20100318184 | Spence | Dec 2010 | A1 |
20100331971 | Keranen et al. | Dec 2010 | A1 |
20100331973 | Keranen | Dec 2010 | A1 |
20110015729 | Jimenez et al. | Jan 2011 | A1 |
20110098802 | Braido et al. | Apr 2011 | A1 |
20110106247 | Miller et al. | May 2011 | A1 |
20110137397 | Chau et al. | Jun 2011 | A1 |
20110178597 | Navia et al. | Jul 2011 | A9 |
20110196480 | Cartledge | Aug 2011 | A1 |
20110208297 | Tuval et al. | Aug 2011 | A1 |
20110208298 | Tuval et al. | Aug 2011 | A1 |
20110218621 | Antonsson et al. | Sep 2011 | A1 |
20110224785 | Hacohen | Sep 2011 | A1 |
20110245911 | Quill et al. | Oct 2011 | A1 |
20110288634 | Tuval et al. | Nov 2011 | A1 |
20110295361 | Claiborne, III et al. | Dec 2011 | A1 |
20110319989 | Lane et al. | Dec 2011 | A1 |
20110319990 | Macoviak et al. | Dec 2011 | A1 |
20120016464 | Seguin | Jan 2012 | A1 |
20120022629 | Perera et al. | Jan 2012 | A1 |
20120022633 | Olson et al. | Jan 2012 | A1 |
20120053680 | Bolling et al. | Mar 2012 | A1 |
20120059458 | Buchbinder et al. | Mar 2012 | A1 |
20120123529 | Levi et al. | May 2012 | A1 |
20120150287 | Forster et al. | Jun 2012 | A1 |
20120215236 | Matsunaga et al. | Aug 2012 | A1 |
20120259409 | Nguyen et al. | Oct 2012 | A1 |
20120283820 | Tseng et al. | Nov 2012 | A1 |
20120310328 | Olson et al. | Dec 2012 | A1 |
20120316643 | Keranen | Dec 2012 | A1 |
20120323316 | Chau et al. | Dec 2012 | A1 |
20130006352 | Yaron | Jan 2013 | A1 |
20130023985 | Khairkhahan et al. | Jan 2013 | A1 |
20130114214 | Takeguchi et al. | May 2013 | A1 |
20130190857 | Mitra et al. | Jul 2013 | A1 |
20130190865 | Anderson | Jul 2013 | A1 |
20130274873 | Delaloye et al. | Oct 2013 | A1 |
20130310917 | Richter et al. | Nov 2013 | A1 |
20130310928 | Morriss et al. | Nov 2013 | A1 |
20130317598 | Rowe et al. | Nov 2013 | A1 |
20130325114 | McLean et al. | Dec 2013 | A1 |
20130331929 | Mitra et al. | Dec 2013 | A1 |
20140067054 | Chau et al. | Mar 2014 | A1 |
20140074299 | Endou et al. | Mar 2014 | A1 |
20140081394 | Keranen et al. | Mar 2014 | A1 |
20140155997 | Braido | Jun 2014 | A1 |
20140172070 | Seguin | Jun 2014 | A1 |
20140194981 | Menk et al. | Jul 2014 | A1 |
20140200661 | Pintor et al. | Jul 2014 | A1 |
20140236287 | Clague et al. | Aug 2014 | A1 |
20140277417 | Schraut et al. | Sep 2014 | A1 |
20140277419 | Garde et al. | Sep 2014 | A1 |
20140277424 | Oslund | Sep 2014 | A1 |
20140330372 | Weston et al. | Nov 2014 | A1 |
20140343671 | Yohanan et al. | Nov 2014 | A1 |
20140350667 | Braido et al. | Nov 2014 | A1 |
20140358222 | Gorman, III et al. | Dec 2014 | A1 |
20140358224 | Tegels et al. | Dec 2014 | A1 |
20140379074 | Spence et al. | Dec 2014 | A1 |
20140379076 | Vidlund et al. | Dec 2014 | A1 |
20150025623 | Granada et al. | Jan 2015 | A1 |
20150073545 | Braido | Mar 2015 | A1 |
20150073546 | Braido | Mar 2015 | A1 |
20150230921 | Chau et al. | Aug 2015 | A1 |
20150245910 | Righini et al. | Sep 2015 | A1 |
20150282931 | Brunnett et al. | Oct 2015 | A1 |
20150335428 | Keranen | Nov 2015 | A1 |
20150335430 | Loulmet et al. | Nov 2015 | A1 |
20150374493 | Yaron et al. | Dec 2015 | A1 |
20160015514 | Lashinski et al. | Jan 2016 | A1 |
20160074165 | Spence et al. | Mar 2016 | A1 |
20160095705 | Keranen et al. | Apr 2016 | A1 |
20160143732 | Glimsdale | May 2016 | A1 |
20160184095 | Spence et al. | Jun 2016 | A1 |
20160199177 | Spence et al. | Jul 2016 | A1 |
20160256276 | Yaron | Sep 2016 | A1 |
20160346080 | Righini et al. | Dec 2016 | A1 |
20170007399 | Keranen | Jan 2017 | A1 |
20170007402 | Zerkowski et al. | Jan 2017 | A1 |
20170217385 | Rinkleff et al. | Aug 2017 | A1 |
20170266005 | McGuckin, Jr. | Sep 2017 | A1 |
20170273788 | O'Carroll et al. | Sep 2017 | A1 |
20170273789 | Yaron et al. | Sep 2017 | A1 |
20170281337 | Campbell | Oct 2017 | A1 |
20180000580 | Wallace et al. | Jan 2018 | A1 |
20180085217 | Lashinski et al. | Mar 2018 | A1 |
20180206074 | Tanasa et al. | Jul 2018 | A1 |
20180289481 | Dolan | Oct 2018 | A1 |
20180303606 | Rothstein et al. | Oct 2018 | A1 |
20180318073 | Tseng et al. | Nov 2018 | A1 |
20180318080 | Quill et al. | Nov 2018 | A1 |
Number | Date | Country |
---|---|---|
1684644 | Oct 2005 | CN |
1714766 | Jan 2006 | CN |
101588771 | Nov 2009 | CN |
102670332 | Sep 2012 | CN |
19532846 | Mar 1997 | DE |
19546692 | Jun 1997 | DE |
19857887 | Jul 2000 | DE |
19907646 | Aug 2000 | DE |
0103546 | Mar 1984 | EP |
0597967 | May 1994 | EP |
0592410 | Oct 1995 | EP |
0850607 | Jul 1998 | EP |
1432369 | Jun 2004 | EP |
1521550 | Apr 2005 | EP |
1796597 | Jun 2007 | EP |
1296618 | Jan 2008 | EP |
2072027 | Jun 2009 | EP |
1827314 | Dec 2010 | EP |
2620125 | Jul 2013 | EP |
2726018 | May 2014 | EP |
2806829 | Dec 2014 | EP |
2788217 | Jul 2000 | FR |
2815844 | May 2002 | FR |
2004502494 | Jan 2004 | JP |
2008531185 | Aug 2008 | JP |
1271508 | Nov 1986 | SU |
9117720 | Nov 1991 | WO |
9301768 | Feb 1993 | WO |
9829057 | Jul 1998 | WO |
9940964 | Aug 1999 | WO |
9947075 | Sep 1999 | WO |
0041652 | Jul 2000 | WO |
0047139 | Aug 2000 | WO |
0149213 | Jul 2001 | WO |
0154625 | Aug 2001 | WO |
0162189 | Aug 2001 | WO |
0164137 | Sep 2001 | WO |
0176510 | Oct 2001 | WO |
0203892 | Jan 2002 | WO |
0222054 | Mar 2002 | WO |
0236048 | May 2002 | WO |
0247575 | Jun 2002 | WO |
03028558 | Apr 2003 | WO |
03047468 | Jun 2003 | WO |
2005034812 | Apr 2005 | WO |
2005084595 | Sep 2005 | WO |
2006011127 | Feb 2006 | WO |
2006091163 | Aug 2006 | WO |
2006111391 | Oct 2006 | WO |
2006138173 | Dec 2006 | WO |
2005102015 | Apr 2007 | WO |
2007047488 | Apr 2007 | WO |
2007067942 | Jun 2007 | WO |
2007097983 | Aug 2007 | WO |
2008005405 | Jan 2008 | WO |
2008015257 | Feb 2008 | WO |
2008058940 | May 2008 | WO |
2008091515 | Jul 2008 | WO |
2009033469 | Mar 2009 | WO |
2009080801 | Jul 2009 | WO |
2009134701 | Nov 2009 | WO |
2009155561 | Dec 2009 | WO |
2010057262 | May 2010 | WO |
2010121076 | Oct 2010 | WO |
2012063228 | May 2012 | WO |
2013001339 | Jan 2013 | WO |
2013068542 | May 2013 | WO |
2013110722 | Aug 2013 | WO |
2013114214 | Aug 2013 | WO |
2015023579 | Feb 2015 | WO |
2015023862 | Feb 2015 | WO |
2015125024 | Aug 2015 | WO |
2015127264 | Aug 2015 | WO |
2015198125 | Dec 2015 | WO |
2016038017 | Mar 2016 | WO |
2016040881 | Mar 2016 | WO |
2016130820 | Aug 2016 | WO |
2017103833 | Jun 2017 | WO |
Entry |
---|
Kempfert et al., “Minimally invasive off-pump valve-in-a-ring implantation: the atrial transcatheter approach for re-operative mitral valve replacement after failed repair,” European Journal of Cardiothoracic Surgery, 2009, 35:965-969. |
Webb et al., “Transcatheter Valve-in-Valve Implantation for Failed Bioprosthetic Heart Valves,” Journal of the American Heart Association, 11, Apr. 27, 2010. |
Webb et al., “Mitral Valve in Valve,” TCT Sep. 2009, Live Case: 30 Minutes, St. Paul's Hospital/University of British Columbia. |
Wenaweser et al., “Percutaneous Aortic Valve Replacement for Severe Aortic Regurgitation in Degenerated Bioprosthesis: The First Valve Procedure Using Corevalve Revalving System,” Catheterization and Cardiovascular Interventions, 70:760-764, 2007. |
Cheung et al.,“Transapical Transcatheter Mitral Valve-in-Valve Implantation in a Human,” The Society of Thoracic Surgeons, 2009. |
Cheung et al., Live Case Transmissions, NYHA III CHF, Case Summary, Sep. 23, 2010, St. Paul's Hospital/University of British Columbia. |
Shuto et al., “Percutaneous Transvenous Melody Valve-in-Ring Procedure for Mitral Valve Replacement,” J AM Coll Cardiol, 58(24): 2475-2480, 2011. |
Descoutures et al., “Transcatheter Valve-in-Ring Implantation After Failure of Surgical Mitral Repair,” European Journal of Cardio-Thoracic Surgery 44, e8-e15, 2013. |
Weger et al., “First-in-Man Implantation of a Trans-Catheter Aortic Valve in a Mitral Annuloplasty Ring: Novel Treatment Modality for Failed Mitral Valve Repair,” European Journal of Cardio-Thoracic Surgery 39, 1054-1056, 2011. |
Walther et al., “Human Minimally Invasive Off-Pump Valve-in-a-Valve Implantation,” Case Reports, The Society of Thoracic Surgeons, 2008. |
Walther et al., “Valve-in-a-Valve Concept for Transcatheter Minimally Invasive Repeat Xenograph Implantation,” Preclinical Studies, Journal of the American College of Cardiology, 2007. |
Himbert et al., “Transseptal Implantation of a Transcatheter Heart Valve in a Mitral Annuloplasty Ring to Treat Mitral Repair Failure,” Circulation Cardiovascular Interventions, American Heart Association, 2011. |
Himbert, Dominique, “Transvenous Mitral Valve Repair Replacement After Failure of Surgical Ring Annuloplasty,” Research Correspondence, Journal of the American College of Cardiology, 2012. |
Casselman et al., “Reducing Operative Morality in Valvular Reoperations: The “valve in ring” Procedure,” Brief Technique Reports, The Journal of Thoracic and Cardiovascular Surgery, vol. 141, No. 5. May 2011. |
Ma et al., “Double-Crowned Valved Stents for Off-Pump Mitral Valve Replacement,” European Journal of Cardio-Thoracic Surgery, 28, 194-199, 2005. |
Bonhoeffer et at., “Percutaneous Replacement of Pulmonary valve in a Right-Ventricle to Pulmonary-Artery Prosthetic Conduit with Valve Dysfunction,” Early Report, The Lancet, vol. 356, Oct. 21, 2000. |
International Search Report from corresponding PCT case No. PCT/IB2015/000901 dated Feb. 15, 2015. |
Andersen, H.R., et al. “Transluminal Implantation of Artificial Heart Valve. Description of a New Expandable Aortic Valve and Initial Results with implantation by Catheter Technique in Closed Chest Pig,” European Heart Journal, No. 13. pp. 704-708. 1992. |
Andersen, H.R. “History of Percutaneous Aortic Valve Prosthesis,” Herz No. 34. pp. 343-346. 2009. |
Pavcnik, et al. “Development and initial Experimental Evaluation of a Prosthetic Aortic Valve for Transcatheter Placement,” Cardiovascular Radiology, vol. 183, No. 1. pp. 151-154. 1992. |
Bailey, S. “Percutaneous Expandable Prosthetic Valves,” Textbook of Interventional Cardiology vol. 2, 2nd Ed. pp. 1268-1276. 1994. |
Al-Khaja, et al. “Eleven Years' Experience with Carpentier-Edwards Biological Valves in Relation to Survival and Complications,” European Journal of Cardiothoracic Surgery, vol. 3. pp. 305-311. 1989. |
Ross, “Aortic Valve Surgery,” At a meeting of the Council on Aug. 4, 1966. pp. 192-197. |
Sabbah, et al. “Mechanical Factors in the Degeneration of Porcine Bioprosthetic Valves: An Overview,” Journal of Cardiac Surgery, vol. 4, No. 4. pp. 302-309. 1989. |
Wheatley, “Valve Prostheses,” Operative Surgery, 4th ed. pp. 415-424. 1986. |
Uchida, “Modifications of Gianturco Expandable Wire Stents,” American Journal of Roentgenology, vol. 150. pp. 1185-1187. 1986. |
Number | Date | Country | |
---|---|---|---|
20200205970 A1 | Jul 2020 | US |
Number | Date | Country | |
---|---|---|---|
61943125 | Feb 2014 | US | |
61942300 | Feb 2014 | US | |
61865657 | Aug 2013 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14628020 | Feb 2015 | US |
Child | 15912971 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15912971 | Mar 2018 | US |
Child | 16814338 | US |
Number | Date | Country | |
---|---|---|---|
Parent | PCT/US2014/051095 | Aug 2014 | US |
Child | 14628020 | US |